论文部分内容阅读
目的:分析糖尿病患者早期肾损伤时采用尿微量和尿糖联合检验的价值。方法:将2016年1月到2016年12月期间在本院接受治疗的51例糖尿病患者视为实验组,选取同期本院51例健康体检者作为参照组,为两组患者实施尿微量白蛋白与尿糖检测,对比两组患者的临床检测结果。结果:实验组患者尿微量白蛋白、尿糖检测结果均高于参照组患者,差异对比具有统计学意义(p<0.05)。实验组患者的尿微量白蛋白阳性率为66.67%(34/51),尿糖阳性率为88.24%(45/51),数据对比差异显著(p<0.05)。结论:糖尿病患者早期肾损伤时采用尿微量与尿糖联合检验的方式,有助于提升临床诊断的准确率,以便于患者早期治疗,避免糖尿病患者病情的持续发展,临床应用价值显著。
OBJECTIVE: To analyze the value of urine microalbuminuria combined with urine test in the early stage of renal injury in diabetic patients. Methods: From January 2016 to December 2016 in 51 cases of diabetes treated in our hospital as experimental group, select the same period in our hospital 51 cases of healthy physical examination as a reference group for the two groups of patients to implement urine microalbumin And urine test, compared the clinical test results of two groups of patients. Results: The results of urine microalbuminuria and urine glucose in the experimental group were higher than those in the reference group, the difference was statistically significant (p <0.05). The positive rate of urinary albumin in experimental group was 66.67% (34/51) and the positive rate of urine sugar was 88.24% (45/51), the difference was significant (p <0.05). Conclusion: The combination of urinary microalbuminuria and urine glucose test in diabetic patients with early renal injury can improve the accuracy of clinical diagnosis, facilitate the early treatment of patients and avoid the sustained development of patients with diabetes mellitus, and have significant clinical value.